MARKET

NUWE

NUWE

Nuwellis Inc
NASDAQ
0.9645
-0.0345
-3.45%
After Hours: 0.9645 0 0.00% 18:24 05/14 EDT
OPEN
0.9950
PREV CLOSE
0.9990
HIGH
0.9950
LOW
0.9500
VOLUME
21.75K
TURNOVER
--
52 WEEK HIGH
11.66
52 WEEK LOW
0.7506
MARKET CAP
4.22M
P/E (TTM)
-0.1205
1D
5D
1M
3M
1Y
5Y
1D
Nuwellis, Inc. Reports Modest Growth and Strategic Expansion
TipRanks · 19h ago
Nuwellis, Inc. Reports Financial Results for the Quarter Ended March 31, 2025
Press release · 1d ago
Nuwellis price target lowered to $11 from $13 at Roth Capital
TipRanks · 1d ago
Nuwellis Inc reports results for the quarter ended March 31 - Earnings Summary
Reuters · 1d ago
Nuwellis, Inc. (NUWE) Reports Q1 Loss, Lags Revenue Estimates
NASDAQ · 1d ago
Nuwellis GAAP EPS of -$0.69 misses by $0.24, revenue of $1.9M misses by $0.6M
Seeking Alpha · 1d ago
*Nuwellis 1Q Sales $1.9M >NUWE
Dow Jones · 1d ago
NUWELLIS, INC. REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
Reuters · 1d ago
More
About NUWE
More
Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Recently
Symbol
Price
%Change

Webull offers Nuwellis Inc stock information, including NASDAQ: NUWE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUWE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NUWE stock methods without spending real money on the virtual paper trading platform.